Renalytix plc (RNLXY): Cash & Equivalents
Not updated since 2024-06-30. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$4.68M
As of 2024-06-30
$909.0K
As of 2024-09-30
-58.4%
3-year compound annual growth
-10.6%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-06-30 | $4.68M | -81.0% | 2024-09-30, Balance as of period end |
| 2023-06-30 | $24.68M | -40.3% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $41.33M | -36.5% | 2023-09-28, Balance as of period end |
| 2021-06-30 | $65.13M | +389.9% | 2022-10-31, Balance as of period end |
| 2020-06-30 | $13.29M | +62.1% | 2022-08-01, Balance as of period end |
| 2019-06-30 | $8.20M | n/m | 2022-08-01, Balance as of period end |
| 2018-06-30 | $82.0K | n/a | 2020-11-10, Balance as of period end |